FebriDx® US - Lumos Diagnostics
网页Learn about FebriDx®, a rapid point-of-care test device that aids in differentiating between bacterial and non-bacterial acute respiratory infections. FebriDx provides actionable results after 10 minutes, helping reduce unnecessary antibiotic prescriptions and supporting antimicrobial stewardship.
FebriDx - Lumos Diagnostics
网页Explore FebriDx®, a rapid point-of-care test that aids in differentiating between bacterial and non-bacterial acute respiratory infections. Select your region for more information and contact us to learn more about FebriDx.
Lumos Diagnostics Secures $2.98 million from BARDA for FebriDx …
网页6 天之前 · The funding will support a CLIA-waiver clinical study and regulatory submission for Lumos’ FebriDx® test, a diagnostic tool that differentiates between bacterial and non-bacterial acute respiratory infections.
Lumos Diagnostics Sets Stage for US Expansion With New …
网页5 天之前 · The firm will enter studies this month aimed at obtaining CLIA waiver for its FDA-cleared FebriDx assay to distinguish bacterial from nonbacterial infections.
FebriDx®: A Rapid Diagnostic Test for Differentiating Bacterial …
网页2019年11月6日 · FebriDx ® is a rapid, point-of-care diagnostic test that is designed to aid in the differentiation of bacterial and viral acute respiratory infections (ARIs), thus helping to guide decisions regarding the prescription of antibiotics in the outpatient setting. FebriDx carries a CE mark for use in the EU and is also approved in several other ...
Use of the FebriDx - Oxford Academic
网页2024年5月6日 · FebriDx ® is a CE-marked, single-use point-of-care test with markers for bacterial [C-reactive protein (CRP)] and viral [myxovirus resistance protein A (MxA)] infection, using finger-prick blood samples. Results are available after 10–12 min.
Lumos Diagnostics Expanding Rapid Respiratory Test Portfolio …
网页2021年9月2日 · FebriDx, CoviDx, and ViraDx can be deployed when triaging is needed for patients suspected of acute respiratory infection. FebriDx can be used to quickly detect whether an infection is bacterial or viral, or whether there is no infection.
FebriDx for rapid screening of patients with suspected COVID-19 …
网页2022年2月21日 · FebriDx is a single-use, portable test that allows simultaneous qualitative assessment of two infective biomarkers (i.e. CRP and MxA), the combined detection of which enables differentiation between acute viral infections, bacterial infections requiring antibiotics, and other non-infectious conditions.
FebriDx®: A Rapid Diagnostic Test for Differentiating ... - PubMed
网页FebriDx ® is a rapid, point-of-care diagnostic test that is designed to aid in the differentiation of bacterial and viral acute respiratory infections (ARIs), thus helping to guide decisions regarding the prescription of antibiotics in the outpatient setting. FebriDx carries a …
Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care …
网页2021年9月30日 · FebriDx-guided ARI diagnosis demonstrated a US $2.51 billion cost savings compared to the standard of care approach of guiding antibiotic treatment of ARIs in US outpatient settings. The cost savings were driven by the reduction in antibiotic resistance associated with a lower antibiotic prescription rate as well as avoided return visits for ...